Community Capital Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$1.26M Sell
23,800
-7,200
-23% -$378K 2% 26
2023
Q2
$1.68M Hold
31,000
2.33% 14
2023
Q1
$1.55M Hold
31,000
2.04% 18
2022
Q4
$1.43M Hold
31,000
1.86% 25
2022
Q3
$1.2M Hold
31,000
1.57% 27
2022
Q2
$1.16M Buy
+31,000
New +$1.26M 1.4% 31
2022
Q1
Sell
-20,000
Closed -$867K 36
2021
Q4
$850K Buy
20,000
+6,000
+43% +$252K 0.91% 45
2021
Q3
$607K Hold
14,000
0.63% 57
2021
Q2
$599K Hold
14,000
0.61% 60
2021
Q1
$541K Hold
14,000
0.6% 59
2020
Q4
$503K Buy
+14,000
New +$505K 0.61% 54
2019
Q2
Sell
-8,316
Closed -$319K 152
2019
Q1
$319K Hold
8,316
0.39% 79
2018
Q4
$294K Buy
+8,316
New +$302K 0.44% 66

Other funds holding BSX

Community Capital Management's BSX Position: Q3 2023 in Review

Community Capital Management reduced its Boston Scientific (BSX) stake by 23% in Q3 2023, selling an estimated $378K and leaving 23,800 shares worth $1.26M. The position accounts for 2% of the portfolio, ranked #26.

Community Capital Management first reported a position in BSX in Q4 2018 and has held it in 13 quarters since. The position peaked at $1.68M in Q2 2023. 1,056 funds tracked by Wall St. Rank hold BSX as of Q3 2023.

  • Community Capital Management held 23,800 shares of Boston Scientific worth $1.26M as of Q3 2023.
  • Community Capital Management sold 7,200 Boston Scientific shares in Q3 2023, an estimated $378K.
  • Boston Scientific made up 2% of Community Capital Management's portfolio in Q3 2023, its #26 holding.
  • Community Capital Management first reported a position in Boston Scientific in Q4 2018 and has held it in 13 quarters since.
  • Community Capital Management's Boston Scientific position peaked at $1.68M in Q2 2023.
  • 1,056 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2023.

Based on Community Capital Management's 13F filing for Q3 2023, filed 24 Oct 2023.